Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1α,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor- cholecalciferol (Ro 25-6760), on a human colon cancer xenograft

Clinical Cancer Research

Volumn 4, Issue 11, 1998, Pages 2869-2876

  Evans, Stephen R T ^a   Schwartz, Arnold M ^b   Shchepotin, Evgeny I ^a   Uskokovic, Milan ^c   Shchepotin, Igor B ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1ALPHA,25 DIHYDROXY 16 ENE 23 YNE 26,27 HEXAFLUORO 19 NORCHOLECALCIFEROL; CALCITRIOL; CALCITRIOL DERIVATIVE; PLACEBO; RO 25 6760; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CALCITRIOL; CALCIUM; CELL DIVISION; CHOLECALCIFEROL; COLONIC NEOPLASMS; FEMALE; HT29 CELLS; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED;

EID: 0031756064     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Porter, J. D. Reconciling the epidemiology, physiology, and molecular biology of colon cancer. J. Am. Med. Assoc., 268: 1573-1577, 1992.
2. Garland, C. F., and Garland, F. C. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol., 9: 227-231, 1980.
3. Garland, C. F., Comstock, G. W., Garland, F. C., Helsing, K. J., Shaw, E. K., and Gorham, E. D. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet, 1176-1178, 1989.
4. Garland, C., Shekelle, R. B., Barrett-Connor, E., Criqui, M. H., Rossof, A. H., and Paul, O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet, 307-309, 1985.
5. United Kingdom Cancer Research Campaigns Factsheet 5. J. Natl. Cancer Inst., 84: 1775, 1992.
6. 3. Biochem Pharmacol., 38: 3859-3865, 1989.
7. 3 suppresses colonie tumorigenesis induced by repetitive intrarectal injection of N-methyl-N-nitrosurea in rats. Cancer Lett., 55: 149-152, 1990.
8. Buras, R. R., Schumaker, L. M., Davoodi, F., Brenner, R. V., Shabahang, M., Nauta, R. J., and Evans, S. R. T. Vitamin D receptors in breast cancer cells. Breast Cancer Res. Treat., 31: 191-202, 1994.
9. 3 on the growth of soft tissue sarcoma cells as mediated by the vitamin D receptor. Ann. Surg. Oncol., 3: 144-149, 1996.
10. 3 in human malignant melanoma cell lines. J. Surg. Res., 61: 127-133, 1996.
11. 3 receptor as a marker of human colon carcinoma cell line differentiation and its effect on growth inhibition. Cancer Res., 53: 1-7, 1993.
12. 3. Cancer Res., 54: 4057-4064, 1994.
13. Evans, S. R. T., Nolla, J., Hanfelt, J., Shabahang, M., Nauta, R. J., and Shchepotin, I. B. Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer. Clin. Cancer Res., 4: 1591-1595, 1998.
14. Pakkala, S., de Vos, S., Elstner, E., Rude, R. K., Uskokovic, M., Binderup, L., and Koeffler, H. P. Vitamin D analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels. Leuk. Res., 19: 65-72, 1995.
15. Snedecor, G. W., and Cochran, W. G. Statistical Methods, pps. 258-296. Ames, IA: Iowa State University Press, 1976.
16. + in intestinal adenomas from min mice. Cancer Res., 54: 5947-5952, 1994.
17. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. J. Am. Med. Assoc., 19: 264: 1444-1448, 1990.
18. Anzano, M. A., Smith, J., Uskokovic, M., Peer, C., Mullen, L., Letterio, J., Welsh, M., Shrader, M., Logsdon, D., Driver, C., Brown, C., Roberts, A., and Sporn, M. 1α,25-dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analog) for prevention of breast cancer in the rat. Cancer Res., 54: 1653-1656, 1994.
19. 3, vitamin D derivate, on glandular stomach carcinogenesis induced in rats by N-methyl-N′-nitro-N-nitrosoguanidine and sodium chloride. Cancer Res., 56: 2767-2770, 1996.
20. 3 in chemically induced rat colon carcinogenesis. Carcinogenesis (Lond.), 13: 2293-2298, 1992.
21. 3. Carcinogenesis (Lond.), 16: 2091-2097, 1995.
22. 3, inhibits azoxymethane-induced colonic tumorigenesis. Cancer Res., 55: 3050-3054, 1995.
23. 3. Cancer Res., 47: 21-25, 1987.
24. 3, DD-003. Cancer Res., 54: 5148-5153, 1994.
25. 3 on maturation of myeloid leukemic and preleukemic cells. Cancer Treat. Rep., 69: 1399-1406, 1985.
26. kip1 and E-cadherini J. Mol. Endocrinol., 19: 15-27, 1997.
27. 3: a novel class of potential inhibitors of proliferation of human breast cell lines. Cancer Res., 57: 4545-455, 1997.
28. 3 analogs and Paclitaxel on MCF-7 breast cancer cells in vivo. Cancer Res., in press, 1998.